
1. General Information
LENVITIB 4 mg Capsules contain lenvatinib, an oral targeted anticancer medicine. It belongs to the class of medicines called kinase inhibitors. Lenvatinib interferes with signaling pathways involved in tumor growth and the formation of new blood vessels that can supply tumors.
It is a prescription medicine and should not be started, stopped, or dose-adjusted without medical advice.
Exporter Information: Phoenix Exim is a medicine exporter from Nagpur, India, supplying pharmaceutical products for international markets including the USA, UK, Australia, Singapore, Canada, South Korea, and UAE, subject to applicable import and regulatory requirements.
2. Product Information
- Product: LENVITIB 4 mg Capsules
- Active Ingredient: Lenvatinib
- Strength: 4 mg
- Dosage Form: Capsule
- Route: Oral
- Drug Class: Kinase inhibitor / targeted anticancer medicine
- Available Strengths of lenvatinib: 4 mg and 10 mg capsules
Lenvatinib works by inhibiting several kinase targets, including VEGF receptors, FGFRs, PDGFRA, KIT, and RET, which are involved in angiogenesis, tumor growth, and cancer progression.
3. Uses of LENVITIB 4 mg
Lenvatinib is used for specific cancer indications, including:
- Differentiated thyroid cancer (DTC): For certain locally recurrent or metastatic, progressive, radioactive-iodine-refractory disease.
- Renal cell carcinoma (RCC): Used in combination with pembrolizumab as a first-line treatment for advanced RCC, or with everolimus after prior anti-angiogenic therapy.
- Hepatocellular carcinoma (HCC): Used for unresectable liver cancer in appropriate patients.
- Endometrial carcinoma: Used with pembrolizumab for certain advanced cases after previous systemic therapy when patients are not candidates for curative surgery or radiation.
The exact indication and treatment combination must be determined by an oncologist.
4. Benefits of This Medicine
Potential therapeutic benefits of lenvatinib include:
- Helps inhibit pathways involved in cancer-cell growth.
- Helps reduce tumor-supporting blood-vessel formation.
- May slow cancer progression in appropriate patients.
- Provides an oral targeted-treatment option for several cancers.
- Can be used alone or in combination with other anticancer medicines depending on the indication.
The response to treatment varies between patients, and lenvatinib is not appropriate for every type or stage of cancer.
5. Side Effects of LENVITIB 4 mg
Lenvatinib can cause side effects, some of which may be serious. Important potential adverse effects include:
- High blood pressure
- Diarrhea
- Fatigue
- Decreased appetite and weight loss
- Nausea or vomiting
- Protein in the urine
- Liver problems
- Kidney problems
- Bleeding
- Cardiac dysfunction
- Blood-clot-related events
- QT interval prolongation
- Low calcium levels
- Thyroid dysfunction
- Impaired wound healing
- Gastrointestinal perforation or fistula
- Reversible posterior leukoencephalopathy syndrome (RPLS)
Seek prompt medical attention for severe or unusual symptoms.
6. Common Side Effects
Depending on the cancer indication and treatment combination, commonly reported side effects may include:
- Fatigue
- Diarrhea
- Hypertension
- Nausea
- Vomiting
- Decreased appetite
- Weight loss
- Headache
- Muscle or joint pain
- Abdominal pain
- Stomatitis or mouth inflammation
- Rash
- Proteinuria
- Voice changes
- Hand-foot syndrome
- Hypothyroidism
The frequency and severity can vary according to the treatment regimen.
7. How to Use LENVITIB 4 mg
Take LENVITIB exactly as prescribed by your oncologist.
- It is generally taken once daily, depending on the prescribed regimen.
- It may be taken with or without food.
- Take it at approximately the same time each day.
- Swallow capsules whole; do not open, chew, or crush them.
- Do not change the dose or stop treatment without consulting your doctor.
- Your doctor may temporarily interrupt treatment or reduce the dose if significant side effects occur.
Important: A 4 mg capsule does not mean that 4 mg once daily is the appropriate treatment dose for every patient. Lenvatinib dosing differs substantially according to the cancer indication, body weight in some indications, organ function, and treatment combination.
8. How LENVITIB Works
Lenvatinib blocks multiple kinase pathways involved in tumor development. It inhibits VEGF receptors and other targets such as FGFR1–4, PDGFRA, KIT, and RET.
By interfering with these signaling pathways, lenvatinib can reduce signals responsible for angiogenesis (formation of new blood vessels) and tumor-cell proliferation. This can help slow tumor growth and progression in cancers that are responsive to the medicine.
9. Safety Advice
- Use only under specialist medical supervision.
- Blood pressure should be controlled before and monitored during treatment.
- Liver and kidney function may need regular monitoring.
- Your doctor may monitor urine protein and thyroid function.
- Tell your doctor about any history of heart problems, blood clots, bleeding, liver disease, kidney disease, or uncontrolled hypertension.
- Inform your doctor about all medicines, supplements, and herbal products you take.
- Lenvatinib can affect wound healing; your medical team may advise interruption around major surgery.
- It can cause fetal harm, so appropriate contraception should be discussed with the treating physician.
- Breastfeeding is not recommended during treatment.
- Report severe diarrhea, unusual bleeding, chest pain, severe headache, neurological symptoms, or significant changes in blood pressure promptly.
10. Frequently Asked Questions (FAQs)
Q1. What is LENVITIB 4 mg?
LENVITIB 4 mg is a capsule containing lenvatinib, an oral targeted anticancer medicine.
Q2. What is lenvatinib used for?
It is used for certain thyroid, kidney, liver, and endometrial cancers, depending on the specific indication and treatment regimen.
Q3. Is LENVITIB 4 mg a chemotherapy medicine?
Lenvatinib is more specifically classified as a targeted kinase inhibitor rather than traditional cytotoxic chemotherapy.
Q4. Can LENVITIB 4 mg be taken without a prescription?
No. It is a prescription anticancer medicine and should be used under specialist supervision.
Q5. How often is lenvatinib taken?
Many regimens use once-daily oral dosing, but the prescribed dose depends on the cancer type and treatment combination.
Q6. Can I stop LENVITIB if I feel better?
No. Do not discontinue treatment without consulting your oncologist.
Q7. Can LENVITIB cause high blood pressure?
Yes. Hypertension is a common and clinically important adverse effect, so blood pressure monitoring is recommended.
Q8. What should I do if I experience severe side effects?
Contact your treating healthcare professional promptly. Severe symptoms may require dose interruption, dose reduction, or discontinuation.
11. Substitute for LENVITIB 4 mg
The appropriate substitute should not be selected solely by matching the 4 mg strength. A suitable alternative depends on the cancer type, treatment objective, previous therapies, organ function, and oncologist's treatment plan.
Depending on the indication, other targeted anticancer medicines or alternative lenvatinib products may be considered by a healthcare professional. Examples can include other lenvatinib-containing products or different targeted therapies, but they should only be substituted following medical and pharmaceutical verification.
12. SEO Keywords
- LENVITIB 4 mg Capsules exporter from India
- LENVITIB 4 mg Capsules supplier India
- LENVITIB 4 mg Capsules manufacturer and exporter
- Lenvatinib 4 mg Capsules exporter from Nagpur
- Lenvatinib 4 mg medicine supplier India
- Lenvatinib 4 mg oncology medicine exporter
- Lenvatinib capsules wholesale supplier
- Lenvatinib 4 mg pharmaceutical exporter
- LENVITIB 4 mg Capsules international supplier
- Lenvatinib 4 mg for cancer treatment
- Lenvatinib 4 mg targeted cancer medicine
- Lenvatinib capsules bulk supplier India
- Lenvatinib 4 mg export supplier
- Lenvatinib medicine exporter Nagpur India
- LENVITIB 4 mg Capsules for thyroid cancer
- Lenvatinib 4 mg oncology pharmaceutical supplier
- Lenvatinib 4 mg capsules B2B supplier
- Lenvatinib 4 mg medicine wholesale exporter
- Lenvatinib 4 mg pharmaceutical products India
- LENVITIB 4 mg Capsules supplier for USA
- LENVITIB 4 mg Capsules supplier for UK
- LENVITIB 4 mg Capsules supplier for Australia
- LENVITIB 4 mg Capsules supplier for Singapore
- LENVITIB 4 mg Capsules supplier for Canada
- LENVITIB 4 mg Capsules supplier for South Korea
- LENVITIB 4 mg Capsules supplier for UAE
Keywords







